Verona Pharma plc (VRP.L) (LON:VRP – Get Free Report)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 55 ($0.71) and traded as high as GBX 56 ($0.73). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.71), with a volume of 70,791 shares.
Verona Pharma plc (VRP.L) Trading Up 5.8 %
The company has a debt-to-equity ratio of 6.85, a quick ratio of 2.47 and a current ratio of 2.99. The firm has a fifty day moving average price of GBX 55 and a 200 day moving average price of GBX 55. The company has a market cap of £228.00 million and a price-to-earnings ratio of -1.68.
About Verona Pharma plc (VRP.L)
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.
Read More
- Five stocks we like better than Verona Pharma plc (VRP.L)
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- 3 Tickers Leading a Meme Stock Revival
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- What is the Dogs of the Dow Strategy? Overview and Examples
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.